Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland.
Study Goal
The researchers aimed to evaluate whether long-term gluten-free diet (GFD)-treated dermatitis herpetiformis (DH) patients experience persistent gastrointestinal symptoms and a reduced quality of life.
Results Summary
The study found no significant differences in gastrointestinal symptoms or quality of life between GFD-treated DH patients and healthy controls, but DH patients had less severe symptoms and better quality of life compared to celiac disease controls. Female DH patients reported more severe gastrointestinal symptoms and reduced vitality than males.
Population
78 long-term GFD-treated dermatitis herpetiformis patients (median age 57, 51% male), compared to 110 healthy controls and 371 treated celiac disease controls.
Effective Dosage
Not specified
Duration
Long-term (specific duration not mentioned)
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
long-term gluten-free diet (GFD) | no change | gastrointestinal symptoms or quality of life | treated DH patients compared with healthy controls | no significant change | significant differences were not detected | #1 |
long-term gluten-free diet (GFD) | decrease | gastrointestinal symptoms | treated DH patients compared with celiac disease controls | - | had less severe gastrointestinal symptoms | #2 |
long-term gluten-free diet (GFD) | increase | quality of life | treated DH patients compared with celiac disease controls | - | increased quality of life | #3 |
- | increase | gastrointestinal symptoms | female DH patients compared with male DH patients | - | had more severe gastrointestinal symptoms | #4 |
- | decrease | vitality | female DH patients compared with male DH patients | - | reduced vitality | #5 |
gluten-free diet (GFD) | no change | gastrointestinal symptoms or quality of life | DH patients | - | did not have any influence | #6 |
long-term gluten-free diet (GFD) | no change | burden of dietary treatment | long-term GFD-treated DH patients | - | do not suffer from the burden of dietary treatment | #7 |
long-term gluten-free diet (GFD) | no change | quality of life | long-term GFD-treated DH patients | - | have a quality of life comparable to that of controls | #8 |
BACKGROUND: Dermatitis herpetiformis (DH) is a cutaneous manifestation of celiac disease. Both conditions are treated with a restrictive life-long gluten-free diet (GFD). Treated celiac disease patients have been shown to have more severe gastrointestinal symptoms and inferior quality of life compared with healthy controls, but evidence regarding quality of life in DH is lacking. OBJECTIVE: The aim was to evaluate whether long-term GFD-treated DH patients suffer from persistent gastrointestinal symptoms and if they experience a drawdown in quality of life. METHODS: Gastrointestinal symptoms and quality of life were assessed in 78 long-term GFD-treated DH patients using the validated Gastrointestinal Symptom Rating Scale, Psychological General Well-Being and Short Form 36 Health Survey questionnaires. The findings were compared with 110 healthy controls, population-based reference values and 371 treated celiac disease controls. RESULTS: The median age of the DH patients at the time of the study was 57 years, and 51 % were male. Significant differences in gastrointestinal symptoms or quality of life were not detected when treated DH patients were compared with healthy controls, but treated DH patients had less severe gastrointestinal symptoms and increased quality of life compared with celiac disease controls. Female DH patients had more severe gastrointestinal symptoms and reduced vitality compared with male DH patients. The presence of skin symptoms and the adherence to or duration of GFD did not have any influence on gastrointestinal symptoms or quality of life. CONCLUSION: We conclude that long-term GFD-treated DH patients do not suffer from the burden of dietary treatment and have a quality of life comparable to that of controls.